The phthalocyanine prototype derivative Alcian blue is the first synthetic agent with selective anti-human immunodeficiency virus activity due to its gp120 glycan-binding potential

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 11, 2009, Pages 4852-4859

  François, Katrien O ^a   Pannecouque, Christophe ^a   Auwerx, Joeri ^a   Lozano, Virginia ^b   Pérez Pérez, Maria Jésus ^b   Schols, Dominique ^a   Balzarini, Jan ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^b INSTITUTO DE QUÍMICA MÉDICA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALCIAN BLUE; GLYCAN; GLYCOPROTEIN GP 120;

AMINO ACID SUBSTITUTION; ANTIVIRAL ACTIVITY; ANTIVIRAL SUSCEPTIBILITY; ARTICLE; CD4+ T LYMPHOCYTE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG PROTEIN BINDING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; VIRUS CELL INTERACTION; VIRUS MUTANT; VIRUS STRAIN; VIRUS TRANSMISSION;

ALCIAN BLUE; ANTI-HIV AGENTS; CELLS, CULTURED; DRUG RESISTANCE, VIRAL; GIANT CELLS; GLYCOSYLATION; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; MUTATION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 70350315081     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00811-09     Document Type: Article

References (39)

1. Alen, M. M. F., S. J. F. Kaptein, T. De Burghgraeve, J. Balzarini, J. Neyts, and D. Schols. 2009. Antiviral activity of carbohydrate-binding agents and the role of DC-SIGN in dengue virus infection. Virology 387:67-75.
2. Balzarini, J., K. Van Laethem, S. Hatse, K. Vermeire, E. De Clercq, W. Peumans, E. Van Damme, A.-M. Vandamme, A. Bolmstedt, and D. Schols. 2004. Profile of resistance of human immunodeficiency virus to mannosespecific plant lectins. J. Virol. 78:10617-10627. (Pubitemid 39258388)
3. Balzarini, J., K. Van Laethem, S. Hatse, M. Froeyen, W. Peumans, E. Van Damme, and D. Schols. 2005. Carbohydrate-binding agents cause deletions of highly conserved glycosylation sites in HIV gp120: a new therapeutic concept to hit the Achilles heel of HIV. J. Biol. Chem. 280:41005-41014.
4. Balzarini, J. 2006. Inhibition of HIV entry by carbohydrate-binding proteins. Antivir. Res. 71:237-247.
5. Balzarini, J. 2007. Targeting the glycans of glycoproteins: a novel paradigm for antiviral therapy. Nat. Rev. Microbiol. 5:583-597.
6. Balzarini, J. 2005. Targeting the glycans of gp120: a novel approach aimed at the Achilles heel of HIV. Lancet Infect. Dis. 5:726-731.
7. Balzarini, J., D. Schols, J. Neyts, E. Van Damme, W. Peumans, and E. De Clercq. 1991. Alpha-(1-3)-and alpha-(1-6)-D-mannose-specific plant lectins are markedly inhibitory to human immunodeficiency virus and cytomegalovirus infections in vitro. Antimicrob. Agents Chemother. 35:410-416.
8. Balzarini, J., and L. Van Damme. 2007. Microbicide drug candidates to prevent HIV infection. Lancet 369:787-797. (Pubitemid 46335821)
9. Balzarini, J., Y. Van Herrewege, K. Vermeire, G. Vanham, and D. Schols. 2007. Carbohydrate-binding agents efficiently prevent dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN)-directed HIV-1 transmission to T lymphocytes. Mol. Pharmacol. 71:3-11.
10. Balzarini, J., K. Van Laethem, D. Daelemans, S. Hatse, A. Bugatti, M. Rusnati, Y. Igarashi, T. Oki, and D. Schols. 2007. Pradimicin A, a carbohydrate-binding nonpeptidic lead compound for treatment of infections with viruses with highly glycosylated envelopes, such as human immunodeficiency virus. J. Virol. 81:362-373. (Pubitemid 44975175)
11. Conneely, A., S. McClean, W. F. Smyth, and G. McMullan. 2001. Study of the mass spectrometric behaviour of phthalocyanine and azo dyes using electrospray ionisation and matrix-assisted laser desorption/ionisation. Rapid Commun. Mass Spectrom. 15:2076-2084.
12. Dairi, T., Y. Hamano, Y. Igarashi, T. Furumai, and T. Oki. 1997. Cloning and nucleotide sequence of the putative polyketide synthase genes for pradimicin biosynthesis from Actinomadura hibisca. Biosci. Biotechnol. Biochem. 61:1445-1453.
13. Dale, M. J., A. C. Jones, P. R. R. Langridge-Smith, K. F. Costello, and P. G. Cummins. 1993. Laser desorption laser photoionization time-of-flight mass spectrometry of dyes. Anal. Chem. 65:793-801.
14. Debnath, A. K., S. Jiang, N. Strick, K. Lin, P. Haberfield, and A. R. Neurath. 1994. Three-dimensional structure-activity analysis of a series of porphyrin derivatives with anti-HIV-1 activity targeted to the V3 loop of the gp120 envelope glycoprotein of the human immunodeficiency virus type 1. J. Med. Chem. 37:9.
15. Ding, L., J. Balzarini, D. Schols, B. Meunier, and E. de Clercq. 1992. Anti-human immunodeficiency virus effects of cationic metalloporphyrin- ellipticine complexes. Biochem. Pharmacol. 44:1675-1679.
16. Dorr, P., M. Westby, S. Dobbs, P. Griffin, B. Irvine, M. Macartney, J. Mori, G. Rickett, C. Smith-Burchnell, C. Napier, R. Webster, D. Armour, D. Price, B. Stammen, A. Wood, and M. Perros. 2005. Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity. Antimicrob. Agents Chemother. 49:4721-4732.
17. Geijtenbeek, T. B., D. S. Kwon, R. Torensma, S. J. van Vliet, G. C. van Duijnhoven, J. Middel, I. L. Cornelissen, H. S. Nottet, V. N. KewalRamani, D. R. Littman, C. G. Figdor, and Y. van Kooyk. 2000. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 100:587-597.
18. Geijtenbeek, T. B., R. Torensma, S. J. van Vliet, G. C. van Duijnhoven, G. J. Adema, Y. van Kooyk, and C. G. Figdor. 2000. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 100:575-585.
19. Japour, A. J., D. L. Mayers, V. A. Johnson, D. R. Kuritzkes, L. A. Beckett, J. M. Arduino, J. Lane, R. J. Black, P. S. Reichelderfer, R. T. Daquila, C. S. Crumpacker, H. Balfour, A. Erice, R. Coombs, D. Katzenstein, J. Lathey, D. Richman, K. Mcintosh, S. Rangan, R. Reichman, W. Scott, M. Ussery, L. Abrams, F. Mccutchan, D. Burke, L. Gardner, C. Roberts, R. Chung, C. Hicks, E. Shellie, A. Fowler, L. Merritt, M. Fujimurajustice, N. Ruiz, K. Wagner, and M. Gail. 1993. Standardized peripheral blood mononuclear cell culture assay for determination of drug susceptibilities of clinical human immunodeficiency virus type 1 isolates. Antimicrob. Agents Chemother. 37:1095-1101.
20. Ji, X., H. Gewurz, and G. T. Spear. 2005. Mannose binding lectin (MBL) and HIV. Mol. Immunol. 42:145-152.
21. Kilby, J. M., S. Hopkins, T. M. Venetta, B. DiMassimo, G. A. Cloud, J. Y. Lee, L. Alldredge, E. Hunter, D. Lambert, D. Bolognesi, T. Matthews, M. R. Johnson, M. A. Nowak, G. M. Shaw, and M. S. Saag. 1998. Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry. Nat. Med. 4:1302-1307.
22. Klasse, P. J., R. Shattock, and J. P. Moore. 2008. Antiretroviral drug-based microbicides to prevent HIV-1 sexual transmission. Annu. Rev. Med. 59:455-471.
23. Kwong, P. D., R. Wyatt, J. Robinson, R. W. Sweet, J. Sodroski, and W. A. Hendrickson. 1998. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 393:648-659.
24. Leonard, C. K., M. W. Spellman, L. Riddle, R. J. Harris, J. N. Thomas, and T. J. Gregory. 1990. Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells. J. Biol. Chem. 265:10373-10382.
25. Lyon, H. O. 2002. Dye purity and dye standardization for biological staining. Biotech. Histochem. 77:57-80.
26. Oki, T., M. Konishi, K. Tomatsu, K. Tomita, K. I. Saitoh, M. Tsunakawa, M. Nishio, T. Miyaki, and H. Kawaguchi. 1988. Pradimicin, a novel class of potent antifungal antibiotics. J. Antibiot. 41:1701-1704. (Pubitemid 18274438)
27. Pauwels, R., K. Andries, J. Desmyter, D. Schols, M. J. Kukla, H. J. Breslin, A. Raeymaeckers, J. Vangelder, R. Woestenborghs, J. Heykants, K. Schellekens, M. A. C. Janssen, E. Declercq, and P. A. J. Janssen. 1990. Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives. Nature 343:470-474. (Pubitemid 120028562)
28. Reitter, J. N., R. E. Means, and R. C. Desrosiers. 1998. A role for carbohydrates in immune evasion in AIDS. Nat. Med. 4:679-684.
29. Schumacher, U., and E. Adam. 1994. Standardization of staining in glycosaminoglycan histochemistry: Alcian blue, its analogues, and diamine methods. Biotech. Histochem. 69:7-17.
30. Scott, J. E. 1972. Histochemistry of Alcian blue. II. The structure of Alcian blue 8GS. Histochemie 30:215-234.
31. Tanabe, A., H. Nakashima, O. Yoshida, N. Yamamoto, O. Tenmyo, and T. Oki. 1988. Inhibitory effect of new antibiotic, pradimicin A on infectivity, cytopathic effect and replication of human immunodeficiency virus in vitro. J. Antibiot. 41:1708-1710. (Pubitemid 18274440)
32. Tanabe-Tochikura, A., T. S. Tochikura, O. Yoshida, T. Oki, and N. Yamamoto. 1990. Pradimicin A inhibition of human immunodeficiency virus: attenuation by mannan. Virology 176:467-473. (Pubitemid 20177036)
33. Van Damme, E. J. M., A. K. Allen, and W. J. Peumans. 1988. Related mannose-specific lectins from different species of the family Amaryllidaceae. Physiol. Plant 73:52-57.
34. Van Damme, E. J. M., W. F. Broekaert, and W. J. Peumans. 1988. The Urtica dioica agglutinin is a complex mixture of isolectins. Plant Physiol. 86:598-601.
35. Van Laethem, K., Y. Schrooten, P. Lemey, E. Van Wijngaerden, S. De Wit, M. Van Ranst, and A. M. Vandamme. 2005. A genotypic resistance assay for the detection of drug resistance in the human immunodeficiency virus type 1 envelope gene. J. Virol. Methods 123:25-34. (Pubitemid 39593730)
36. Vzorov, A. N., D. W. Dixon, J. S. Trommel, L. G. Marzilli, and R. W. Compans. 2002. Inactivation of human immunodeficiency virus type 1 by porphyrins. Antimicrob. Agents Chemother. 46:3917-3925.
37. Vzorov, A. N., L. G. Marzilli, R. W. Compans, and D. W. Dixon. 2003. Prevention of HIV-1 infection by phthalocyanines. Antivir. Res. 59:99-109.
38. Whiteman, P. 1973. Quantitative measurement of Alcian blue glycosaminoglycans complexes. Biochem. J. 131:343-350.
39. Wyatt, R., P. D. Kwong, E. Desjardins, R. W. Sweet, J. Robinson, W. A. Hendrickson, and J. G. Sodroski. 1998. The antigenic structure of the HIV gp120 envelope glycoprotein. Nature 393:705-711. (Pubitemid 28289663)